| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |